tradingkey.logo
tradingkey.logo
Suchen

Inogen Inc

INGN
Zur Watchlist hinzufügen
6.600USD
-0.050-0.75%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
179.73MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Inogen Inc Unternehmen

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Inogen Inc Informationen

BörsenkürzelINGN
Name des UnternehmensInogen Inc
IPO-datumFeb 14, 2014
CEOSmith (Kevin R. M)
Anzahl der mitarbeiter766
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 14
Addresse859 Ward Drive
StadtGOLETA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl93111
Telefon18055620500
Websitehttps://www.inogen.com/
BörsenkürzelINGN
IPO-datumFeb 14, 2014
CEOSmith (Kevin R. M)

Führungskräfte von Inogen Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
74.35K
+37.77%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
74.35K
+37.77%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
37.19K
+75.50%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Ryan Peterson
Mr. Ryan Peterson
Associate Director - Investor Relations
Associate Director - Investor Relations
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
74.35K
+37.77%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
74.35K
+37.77%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
37.19K
+75.50%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Inogen Inc?

Die fünf größten Anteilseigner von Inogen Inc sind: Mr. Michael J. Bourque

Wie viele Institutionen halten Anteile an Inogen Inc (INGN)?

Mit Stand vom 2026Q1 halten 294 Institutionen Anteile an Inogen Inc, mit einem Gesamtmarktwert von etwa 20.74M, was 75.89% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -3285676.00 gestiegen.